Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1982 3
1983 3
1984 6
1985 5
1986 3
1987 10
1988 9
1989 8
1990 6
1991 8
1992 5
1993 4
1994 10
1995 15
1996 9
1997 3
1998 4
1999 4
2000 12
2001 13
2002 15
2003 35
2004 18
2005 38
2006 46
2007 45
2008 58
2009 49
2010 55
2011 85
2012 102
2013 98
2014 112
2015 117
2016 139
2017 138
2018 158
2019 148
2020 163
2021 162
2022 168
2023 183
2024 176
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,220 results

Results by year

Filters applied: . Clear all
Page 1
Targeting cyclin-dependent kinase 9 in cancer therapy.
Shen YL, Wang YM, Zhang YX, Ma SJ, Yang LH, Zhao CG, Huang XY. Shen YL, et al. Among authors: zhang yx. Acta Pharmacol Sin. 2022 Jul;43(7):1633-1645. doi: 10.1038/s41401-021-00796-0. Epub 2021 Nov 22. Acta Pharmacol Sin. 2022. PMID: 34811514 Free PMC article. Review.
To the Editor.
Zhang YX, Wang SR. Zhang YX, et al. Blood Press Monit. 2020 Dec;25(6):372. doi: 10.1097/MBP.0000000000000483. Blood Press Monit. 2020. PMID: 33156040 No abstract available.
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial.
Zhou HQ, Zhang YX, Chen G, Yu QT, Zhang H, Wu GW, Wu D, Lin YC, Zhu JF, Chen JH, Hu XH, Lan B, Zhou ZQ, Lin HF, Wang ZB, Lei XL, Pan SM, Chen LM, Zhang J, Kong TD, Yao JC, Zheng X, Li F, Zhang L, Fang WF. Zhou HQ, et al. Among authors: zhang yx. Signal Transduct Target Ther. 2024 Aug 13;9(1):215. doi: 10.1038/s41392-024-01927-9. Signal Transduct Target Ther. 2024. PMID: 39134529 Free PMC article. Clinical Trial.
[Progress on the oocyte cryopreservation technology assessment].
Bai F, Liu C, Zhang YX, Ma Y, Wang DY, Zhang YN. Bai F, et al. Among authors: zhang yx. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 May 6;54(5):577-580. doi: 10.3760/cma.j.cn112150-20190723-00592. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32388963 Review. Chinese.
Emerging roles of hydrogen sulfide in colorectal cancer.
Jiang ZL, Liu Y, Zhang CH, Chu T, Yang YL, Zhu YW, Wang Y, Liu YF, Zhang YX, Feng ZF, Ji XY, Wu DD. Jiang ZL, et al. Among authors: zhang yx. Chem Biol Interact. 2024 Nov 1;403:111226. doi: 10.1016/j.cbi.2024.111226. Epub 2024 Sep 3. Chem Biol Interact. 2024. PMID: 39237072 Review.
2,220 results